NCT00000681View on ClinicalTrials.gov

A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1993

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Bleomycin sulfate

DRUG

Vincristine sulfate

DRUG

Doxorubicin hydrochloride

DRUG

Zidovudine

DRUG

Sargramostim

Trial Locations (5)

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

15213

Pitt CRS, Pittsburgh

90095

UCLA CARE Center CRS, Los Angeles

900331079

USC CRS, Los Angeles

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000681 - A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter